HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.

Abstract
Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P less than 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.
AuthorsG A Filice, C Pomeroy
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 35 Issue 4 Pg. 780-2 (Apr 1991) ISSN: 0066-4804 [Print] United States
PMID2069389 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Clindamycin
Topics
  • Animals
  • Clindamycin (therapeutic use)
  • Female
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Pneumonia (drug therapy)
  • Toxoplasmosis, Animal (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: